Jiménez-Nieto L C, Ladero J M, Fernández-Gundín M J, Robledo A
Department of Medicine, Hospital Universitario San Carlos, Universidad Complutense, Madrid, Spain.
Dermatologica. 1989;178(3):136-7. doi: 10.1159/000248411.
Acetylator phenotype has been determined with sulfamethazine in 64 psoriatic patients and in 157 normal control subjects. Forty patients (62.5%) versus 90 control subjects (57.3%) were slow acetylators (p = NS). However, 81% of the 27 patients with psoriatic siblings were slow acetylators (p less than 0.05). Slow acetylator phenotype may be a genetic risk factor for the development of psoriasis.
已用磺胺二甲嘧啶对64例银屑病患者和157名正常对照者测定了乙酰化代谢表型。40例患者(62.5%)为慢乙酰化代谢者,而90名对照者(57.3%)为慢乙酰化代谢者(p=无显著性差异)。然而,在27例有银屑病亲属的患者中,81%为慢乙酰化代谢者(p<0.05)。慢乙酰化代谢表型可能是银屑病发病的一个遗传危险因素。